1. Home
  2. WETH vs NRXS Comparison

WETH vs NRXS Comparison

Compare WETH & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WETH

Wetouch Technology Inc.

HOLD

Current Price

$1.68

Market Cap

26.1M

Sector

N/A

ML Signal

HOLD

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$2.63

Market Cap

25.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WETH
NRXS
Founded
1992
2011
Country
China
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
26.1M
25.8M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
WETH
NRXS
Price
$1.68
$2.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
90.6K
51.1K
Earning Date
11-12-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
81.55
N/A
EPS
0.62
N/A
Revenue
$43,519,385.00
$3,362,320.00
Revenue This Year
N/A
$31.05
Revenue Next Year
N/A
$137.61
P/E Ratio
$2.82
N/A
Revenue Growth
6.08
36.89
52 Week Low
$0.76
$1.33
52 Week High
$3.68
$6.20

Technical Indicators

Market Signals
Indicator
WETH
NRXS
Relative Strength Index (RSI) 37.09 47.00
Support Level $1.75 $2.50
Resistance Level $2.04 $2.78
Average True Range (ATR) 0.17 0.15
MACD -0.04 0.01
Stochastic Oscillator 4.26 39.41

Price Performance

Historical Comparison
WETH
NRXS

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R&D, production, and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for the automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots, and charging stations. The company sells touchscreen products both domestically in China and internationally. The company generates the majority of its revenue from the PRC, followed by the Republic of China and Korea.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: